Exclusive: The argument for President Trump’s “Great Wall” across the U.S. southern border would be severely undercut if America expanded legalization of personal drug use, reports Jonathan Marshall.
By Jonathan Marshall
Attention deficit disorder isn’t usually a welcome presidential attribute, but Mexicans can be thankful that Donald Trump has temporarily shifted his focus away from their country to start fights instead with Iran, the European Union, China, California and the U.S. news media.
The last time Trump addressed Mexico, right after the election, the peso fell 17 percent. Within days of his inauguration, Trump demanded that Mexico pay for a border wall, prompting cancellation of his planned summit meeting with Mexican President Enrique Pena Nieto.
As former Mexican Ambassador Arturo Sarukhan lamented, “it took only one week of bilateral engagement between the new U.S. administration and Mexico to throw the relationship into a tailspin.” That relationship would be better if Trump had stuck to the view he expressed in November 2015: “I don’t care about Mexico, honestly. I really don’t care about Mexico.”
Someday soon, however, Trump will rediscover his interest in Mexico, and relations will likely suffer again. But Mexico need not take his abuse lying down. As the buyer of more than a quarter trillion dollars in U.S. exports — the second-largest market in the world for U.S. goods — Mexico has some leverage if Trump tries to play rough with tariffs and trade.
And if Trump persists in sending a bill to Mexico City for his wall, Pena should seriously consider sending a bill in return to Washington to pay for the U.S. drug war.
High Cost to Mexico
For years now, Mexico has paid an extraordinarily high price in lives and social disruption for Washington’s insistence that North America’s drug problem be tackled south of the border, where the drugs are grown and transported, rather than primarily in clinics and halfway houses at home to treat the medical and psychological issues of users.
Successive administrations,…
